Yogendra Nayak

1.9k total citations
81 papers, 1.3k citations indexed

About

Yogendra Nayak is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Yogendra Nayak has authored 81 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 15 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in Yogendra Nayak's work include Computational Drug Discovery Methods (12 papers), Synthesis and biological activity (9 papers) and Phytochemicals and Antioxidant Activities (8 papers). Yogendra Nayak is often cited by papers focused on Computational Drug Discovery Methods (12 papers), Synthesis and biological activity (9 papers) and Phytochemicals and Antioxidant Activities (8 papers). Yogendra Nayak collaborates with scholars based in India, Australia and United Arab Emirates. Yogendra Nayak's co-authors include Usha Y. Nayak, Sanjay Garg, Reema Narayan, B. S. Jayashree, K. Sreedhara Ranganath Pai, Swastika Maity, Chetan Hasmukh Mehta, Akhil Suresh, Shivaprasad Gadag and Gopal Venkatesh Shavi and has published in prestigious journals such as Scientific Reports, Coordination Chemistry Reviews and International Journal of Molecular Sciences.

In The Last Decade

Yogendra Nayak

76 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yogendra Nayak India 22 364 235 224 193 161 81 1.3k
Balak Das Kurmi India 20 437 1.2× 369 1.6× 313 1.4× 165 0.9× 254 1.6× 136 1.4k
Md. Lutful Amin Bangladesh 12 328 0.9× 165 0.7× 268 1.2× 187 1.0× 189 1.2× 16 1.1k
Usama A. Fahmy Saudi Arabia 24 459 1.3× 542 2.3× 286 1.3× 106 0.5× 158 1.0× 84 1.7k
Raj Kumar Narang India 17 268 0.7× 253 1.1× 287 1.3× 345 1.8× 227 1.4× 66 1.4k
Kalvatala Sudhakar India 16 433 1.2× 305 1.3× 176 0.8× 113 0.6× 125 0.8× 38 1.2k
Dhanalekshmi Unnikrishnan Meenakshi India 21 450 1.2× 158 0.7× 143 0.6× 103 0.5× 118 0.7× 45 1.3k
Hanna Kumpulainen Finland 5 601 1.7× 151 0.6× 206 0.9× 305 1.6× 189 1.2× 8 1.3k
Agha Zeeshan Mirza Pakistan 18 516 1.4× 108 0.5× 191 0.9× 159 0.8× 155 1.0× 66 1.5k
Muhammad Wahab Amjad Saudi Arabia 20 439 1.2× 175 0.7× 285 1.3× 395 2.0× 163 1.0× 54 1.4k
Hitesh Kulhari India 22 379 1.0× 226 1.0× 402 1.8× 118 0.6× 291 1.8× 53 1.2k

Countries citing papers authored by Yogendra Nayak

Since Specialization
Citations

This map shows the geographic impact of Yogendra Nayak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yogendra Nayak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yogendra Nayak more than expected).

Fields of papers citing papers by Yogendra Nayak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yogendra Nayak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yogendra Nayak. The network helps show where Yogendra Nayak may publish in the future.

Co-authorship network of co-authors of Yogendra Nayak

This figure shows the co-authorship network connecting the top 25 collaborators of Yogendra Nayak. A scholar is included among the top collaborators of Yogendra Nayak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yogendra Nayak. Yogendra Nayak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boodida, Sathyanarayana, et al.. (2025). Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review. International Immunopharmacology. 147. 113979–113979. 9 indexed citations
2.
Nayak, Yogendra, et al.. (2025). Fabrication and evaluation of self-assembled folic acid surface modified Nintedanib mixed micelles to treat Idiopathic Pulmonary Fibrosis. Journal of Drug Delivery Science and Technology. 107. 106801–106801. 1 indexed citations
3.
Dastidar, Somasish Ghosh, et al.. (2025). Exploring TMPRSS2 Drug Target to Combat Influenza and Coronavirus Infection. Scientifica. 2025(1). 3687892–3687892. 1 indexed citations
4.
Nayak, Yogendra, et al.. (2025). Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions. Cell Biochemistry and Biophysics. 83(3). 2669–2701. 2 indexed citations
5.
6.
Soliman, Sameh S. M., Alshaimaa M. Hamoda, Yogendra Nayak, Ahmed Mostafa, & Rania Hamdy. (2024). Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2. European Journal of Medicinal Chemistry. 276. 116671–116671. 2 indexed citations
7.
Mehta, Chetan Hasmukh, et al.. (2024). Development of Epigallocatechin 3-gallate-Loaded Hydrogel Nanocomposites for Oral Submucous Fibrosis. AAPS PharmSciTech. 25(4). 66–66. 4 indexed citations
8.
Mehta, Chetan Hasmukh, et al.. (2023). Polyphenol-based targeted therapy for oral submucous fibrosis. Inflammopharmacology. 31(5). 2349–2368. 15 indexed citations
9.
Manandhar, Suman, et al.. (2023). Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease. Advanced Pharmaceutical Bulletin. 13(4). 688–700. 29 indexed citations
10.
Maity, Swastika, et al.. (2023). Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. Inflammopharmacology. 31(3). 1167–1182. 7 indexed citations
11.
Maity, Swastika, Chetan Hasmukh Mehta, Usha Y. Nayak, et al.. (2023). Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer. Scientific Reports. 13(1). 7947–7947. 15 indexed citations
12.
Gadag, Shivaprasad, Reema Narayan, N. S. Jayalakshmi, et al.. (2022). Transpapillary iontophoretic delivery of resveratrol loaded transfersomes for localized delivery to breast cancer. Biomaterials Advances. 140. 213085–213085. 13 indexed citations
13.
Hamdy, Rania, Bahgat Fayed, Ahmed Mostafa, et al.. (2021). Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity. International Journal of Molecular Sciences. 22(16). 9057–9057. 15 indexed citations
14.
Bhat, Kumar M. R., et al.. (2021). Prophylactic effect of Trigonella foenum-graecum L. seed extract on inflammatory markers and histopathological changes in high-fat-fed ovariectomized rats. Journal of Traditional and Complementary Medicine. 12(2). 131–140. 8 indexed citations
15.
Maity, Swastika, et al.. (2020). Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study. Archives of Medical Research. 52(1). 38–47. 47 indexed citations
16.
Narayan, Reema, et al.. (2017). Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting. Life Sciences. 183. 11–20. 29 indexed citations
17.
Narayan, Reema, Mohan Singh, Om Prakash Ranjan, et al.. (2016). Development of risperidone liposomes for brain targeting through intranasal route. Life Sciences. 163. 38–45. 91 indexed citations
18.
Joseph, Lebana J., et al.. (2011). Radioprotective Effect of Ocimum sanctum and Amifostine on the Salivary Gland of Rats After Therapeutic Radioiodine Exposure. Cancer Biotherapy and Radiopharmaceuticals. 26(6). 737–743. 18 indexed citations
19.
Jayashree, B. S., et al.. (2011). Synthesis of 3-methylflavones and their antioxidant and antibacterial activities. Medicinal Chemistry Research. 21(8). 1991–1996. 11 indexed citations
20.
Jayashree, B. S., et al.. (2008). ANTIOXIDANT ANALGESIC AND ANTI-INFLAMMATORY ACTIVITIES OF SOME SELECTED HETEROARYL SUBSTITUTED COUMARINS. 2. 404–410. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Balak Das Kurmi Breakdown of academic impact, for papers by Md. Lutful Amin Breakdown of academic impact, for papers by Usama A. Fahmy Breakdown of academic impact, for papers by Raj Kumar Narang Breakdown of academic impact, for papers by Kalvatala Sudhakar Breakdown of academic impact, for papers by Dhanalekshmi Unnikrishnan Meenakshi Breakdown of academic impact, for papers by Hanna Kumpulainen Breakdown of academic impact, for papers by Agha Zeeshan Mirza Breakdown of academic impact, for papers by Muhammad Wahab Amjad Breakdown of academic impact, for papers by Hitesh Kulhari
Rankless by CCL
2026